Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

CDF658FEC771AD508725857500618B13 Hearing Summary




PUBLIC
BILL SUMMARY For HB20-1061

SENATE COMMITTEE ON HEALTH & HUMAN SERVICES
Date May 27, 2020      
Location HCR 0112



HB20-1061 - Referred to Senate Appropriations


11:45:27 AM  

Senators Priola and Moreno, bill sponsors, presented House Bill 20-1061. This bill allows pharmacists to prescribe and dispense HIV prevention medication if the pharmacist receives a standing order, as developed by the Colorado Department of Public Health and Environment (CDPHE), or prescribes the medication in accordance with the statewide drug therapy protocol. When prescribing the medication, a pharmacist must:

  • hold a current license to practice in Colorado;
  • be engaged in the practice of pharmacy;
  • have earned a doctorate degree and have at least 5 years of practice experience;
  • carry adequate liability insurance; and
  • complete a training program accredited by the Accreditation Council for Pharmacy Education.

 

Six months after the effective date of the bill, the Board of Pharmacy, the Medical Board, and the Board of Nursing must develop a statewide drug therapy protocol. When creating the protocol, the boards must consider physician referrals, lab testing, appropriate referrals and counseling per federal guidelines, and patient follow-up care. Starting on June 1, 2020, the CDPHE must implement and maintain a standing order until the statewide drug therapy protocol is developed.

 

This bill also requires individual and group health benefit plans to provide coverage for HIV prevention medication prescribed by a pharmacist, except for integrated health delivery systems, which are exempt from the requirement. The carrier must provide the pharmacist an adequate consultative fee or dispensing fee and reimburse any in-network provider when prescribing and dispensing HIV prevention drugs. In addition, a carrier cannot require a patient to undergo step therapy or receive prior authorization before a pharmacist can prescribe and dispense a HIV infection drug.

11:49:51 AM  

Committee questions and discussion followed.

12:04:02 PM  

There was no in-person testimony on the bill.

The following individuals submitted written testimony on the bill (Attachment B):

Michael Crews, One Colorado, testified in support of the bill.

Emily Zodvorny, Pharmacists Society, testified in support of the bill.



12:05:02 PM
Motion Refer House Bill 20-1061 to the Committee on Appropriations.
Moved Winter
Seconded
Crowder No
Ginal Yes
Smallwood No
Winter Yes
Fields Yes
Final YES: 3   NO: 2   EXC: 0   ABS:  0   FINAL ACTION:  PASS






Colorado legislature email addresses ending in @state.co.us are no longer active. Please replace @state.co.us with @coleg.gov for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details